{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T19:33:40Z","timestamp":1777059220219,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,13]]},"DOI":"10.7759\/cureus.69341","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:09:21Z","timestamp":1726240161000},"source":"Crossref","is-referenced-by-count":2,"title":["Safety and Efficacy of Fixed-Dose Combination of Adapalene and Benzoyl Peroxide in Acne Vulgaris Treatment: A Systematic Review of Clinical Trials"],"prefix":"10.7759","author":[{"given":"Komal","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syeda","family":"Sakina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Behram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarosh Khan","family":"Jadoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Tasneem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5694\/mja16.00516","article-title":"Modern management of acne","volume":"206","author":"Cooper AJ","year":"2017","unstructured":"Cooper AJ, Harris VR. Modern management of acne. Med J Aust. 2017, 206:41-5. 10.5694\/mja16.00516","journal-title":"Med J Aust"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15280","article-title":"The prevalence, risk factors, and psychosocial impacts of acne vulgaris in medical students: a literature review","volume":"60","author":"Sachdeva M","year":"2021","unstructured":"Sachdeva M, Tan J, Lim J, Kim M, Nadeem I, Bismil R. The prevalence, risk factors, and psychosocial impacts of acne vulgaris in medical students: a literature review. Int J Dermatol. 2021, 60:792-8. 10.1111\/ijd.15280","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos T","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al.. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2163-96. 10.1016\/S0140-6736(12)61729-2","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00438-6","article-title":"Quality-of-life research in acne vulgaris: current status and future directions","volume":"20","author":"Marron SE","year":"2019","unstructured":"Marron SE, Chernyshov PV, Tomas-Aragones L. Quality-of-life research in acne vulgaris: current status and future directions. Am J Clin Dermatol. 2019, 20:527-38. 10.1007\/s40257-019-00438-6","journal-title":"Am J Clin Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams HC","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012, 379:361-72. 10.1016\/S0140-6736(11)60321-8","journal-title":"Lancet"},{"key":"ref6","article-title":"Acne vulgaris: diagnosis and treatment","volume":"100","author":"Oge' LK","year":"2019","unstructured":"Oge' LK, Broussard A, Marshall MD. Acne vulgaris: diagnosis and treatment. Am Fam Physician. 2019, 100:475-84.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62715-3","article-title":"Systematic review of the epidemiology of acne vulgaris","volume":"10","author":"Heng AH","year":"2020","unstructured":"Heng AH, Chew FT. Systematic review of the epidemiology of acne vulgaris. Sci Rep. 2020, 10:5754. 10.1038\/s41598-020-62715-3","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1654075","article-title":"Acne vulgaris: new evidence in pathogenesis and future modalities of treatment","volume":"32","author":"Hazarika N","year":"2021","unstructured":"Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021, 32:277-85. 10.1080\/09546634.2019.1654075","journal-title":"J Dermatolog Treat"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2021.1939678","article-title":"An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne","volume":"22","author":"Emmerich VK","year":"2021","unstructured":"Emmerich VK, Purvis CG, Feldman SR. An overview of adapalene and benzoyl peroxide once-daily topical gel as a therapeutic option for acne. Expert Opin Pharmacother. 2021, 22:1661-7. 10.1080\/14656566.2021.1939678","journal-title":"Expert Opin Pharmacother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00423-z","article-title":"Topical retinoids in acne vulgaris: a systematic review","volume":"20","author":"Kolli SS","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, Cline A, Feldman SR. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019, 20:345-65. 10.1007\/s40257-019-00423-z","journal-title":"Am J Clin Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study","volume":"57","author":"Thiboutot DM","year":"2007","unstructured":"Thiboutot DM, Weiss J, Bucko A, et al.. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study. J Am Acad Dermatol. 2007, 57:791-9. 10.1016\/j.jaad.2007.06.006","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0345-x","article-title":"Emerging therapies for acne vulgaris","volume":"19","author":"Trivedi MK","year":"2018","unstructured":"Trivedi MK, Bosanac SS, Sivamani RK, Larsen LN. Emerging therapies for acne vulgaris. Am J Clin Dermatol. 2018, 19:505-16. 10.1007\/s40257-018-0345-x","journal-title":"Am J Clin Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/XEB.0000000000000055","article-title":"Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach","volume":"13","author":"Aromataris E","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015, 13:132-40. 10.1097\/XEB.0000000000000055","journal-title":"Int J Evid Based Healthc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/thalassrep13030018","article-title":"Association between glomerular filtration rate and \u03b2-thalassemia major: a systematic review and meta-analysis","volume":"13","author":"Khandker SS","year":"2023","unstructured":"Khandker SS, Jannat N, Sarkar D, et al.. Association between glomerular filtration rate and \u03b2-thalassemia major: a systematic review and meta-analysis. Thalass Rep. 2023, 13:195-205. 10.3390\/thalassrep13030018","journal-title":"Thalass Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16120","article-title":"A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: results of a randomized clinical trial","volume":"23","author":"Khammari A","year":"2024","unstructured":"Khammari A, Kerob D, Demessant AL, Nior\u00e9 M, Dr\u00e9no B. A dermocosmetic regimen is able to mitigate skin sensitivity induced by a retinoid-based fixed combination treatment for acne: results of a randomized clinical trial. J Cosmet Dermatol. 2024, 23:1313-9. 10.1111\/jocd.16120","journal-title":"J Cosmet Dermatol"},{"key":"ref17","article-title":"A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Stein Gold L","year":"2009","unstructured":"Stein Gold L, Tan J, Cruz-Santana A, et al.. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Cutis. 2009, 84:110-6.","journal-title":"Cutis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09209.x","article-title":"Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients","volume":"161","author":"Gollnick HP","year":"2009","unstructured":"Gollnick HP, Draelos Z, Glenn MJ, et al.. Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients. Br J Dermatol. 2009, 161:1180-9. 10.1111\/j.1365-2133.2009.09209.x","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3%\/benzoyl peroxide 2.5% Gel: a randomized, double-blind, parallel-group, controlled study","volume":"17","author":"Stein Gold L","year":"2016","unstructured":"Stein Gold L, Weiss J, Rueda MJ, Liu H, Tanghetti E. Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3%\/benzoyl peroxide 2.5% Gel: a randomized, double-blind, parallel-group, controlled study. Am J Clin Dermatol. 2016, 17:293-303. 10.1007\/s40257-016-0178-4","journal-title":"Am J Clin Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14026","article-title":"Adapalene 0.1%\/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial","volume":"31","author":"Dreno B","year":"2017","unstructured":"Dreno B, Tan J, Rivier M, Martel P, Bissonnette R. Adapalene 0.1%\/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial. J Eur Acad Dermatol Venereol. 2017, 31:737-42. 10.1111\/jdv.14026","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0352-y","article-title":"Prevention and reduction of atrophic acne scars with adapalene 0.3%\/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison","volume":"19","author":"Dr\u00e9no B","year":"2018","unstructured":"Dr\u00e9no B, Bissonnette R, Gagn\u00e9-Henley A, Barankin B, Lynde C, Kerrouche N, Tan J. Prevention and reduction of atrophic acne scars with adapalene 0.3%\/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison. Am J Clin Dermatol. 2018, 19:275-86. 10.1007\/s40257-018-0352-y","journal-title":"Am J Clin Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00454-6","article-title":"Long-term effectiveness and safety of up to 48 weeks\u2019 treatment with topical adapalene 0.3%\/benzoyl peroxide 2.5% gel in the prevention and reduction of atrophic acne scars in moderate and severe facial acne","volume":"20","author":"Dr\u00e9no B","year":"2019","unstructured":"Dr\u00e9no B, Bissonnette R, Gagn\u00e9-Henley A, et al.. Long-term effectiveness and safety of up to 48 weeks\u2019 treatment with topical adapalene 0.3%\/benzoyl peroxide 2.5% gel in the prevention and reduction of atrophic acne scars in moderate and severe facial acne. Am J Clin Dermatol. 2019, 20:725-32. 10.1007\/s40257-019-00454-6","journal-title":"Am J Clin Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21081063","article-title":"Treatment modalities for acne","volume":"21","author":"Fox L","year":"2016","unstructured":"Fox L, Csongradi C, Aucamp M, et al.. Treatment modalities for acne. Molecules. 2016, 21:10.3390\/molecules21081063","journal-title":"Molecules"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10374.x","article-title":"Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study","volume":"165","author":"Dr\u00e9no B","year":"2011","unstructured":"Dr\u00e9no B, Kaufmann R, Talarico S, et al.. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study. Br J Dermatol. 2011, 165:383-90. 10.1111\/j.1365-2133.2011.10374.x","journal-title":"Br J Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13191","article-title":"A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin","volume":"171","author":"Tan J","year":"2014","unstructured":"Tan J, Humphrey S, Vender R, et al.. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene\/benzoyl peroxide plus doxycycline vs. oral isotretinoin. Br J Dermatol. 2014, 171:1508-16. 10.1111\/bjd.13191","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0203-4","article-title":"Use of supplementary patient education material increases treatment adherence and satisfaction among acne patients receiving adapalene 0.1%\/benzoyl peroxide 2.5% gel in primary care clinics: a multicenter, randomized, controlled clinical study","volume":"7","author":"Myhill T","year":"2017","unstructured":"Myhill T, Coulson W, Nixon P, et al.. Use of supplementary patient education material increases treatment adherence and satisfaction among acne patients receiving adapalene 0.1%\/benzoyl peroxide 2.5% gel in primary care clinics: a multicenter, randomized, controlled clinical study. Dermatol Ther (Heidelb). 2017, 7:515-24. 10.1007\/s13555-017-0203-4","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000502575","article-title":"How to increase adherence and compliance in acne treatment? A combined strategy of SMS and visual instruction leaflet","volume":"235","author":"Donnarumma M","year":"2019","unstructured":"Donnarumma M, Fattore D, Greco V, et al.. How to increase adherence and compliance in acne treatment? A combined strategy of SMS and visual instruction leaflet. Dermatology. 2019, 235:463-70. 10.1159\/000502575","journal-title":"Dermatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00650-3","article-title":"Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug","volume":"23","author":"Stein Gold L","year":"2022","unstructured":"Stein Gold L, Baldwin H, Kircik LH, et al.. Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug. Am J Clin Dermatol. 2022, 23:93-104. 10.1007\/s40257-021-00650-3","journal-title":"Am J Clin Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13741","article-title":"Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: a secondary publication","volume":"44","author":"Kawashima M","year":"2017","unstructured":"Kawashima M, Nagare T, Katsuramaki T. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: a secondary publication. J Dermatol. 2017, 44:635-43. 10.1111\/1346-8138.13741","journal-title":"J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2022.4275","article-title":"Adapalene\/benzoyl peroxide gel 0.3%\/2.5% for acne vulgaris","volume":"32","author":"Dr\u00e9no B","year":"2022","unstructured":"Dr\u00e9no B, Layton AM, Troielli P, et al.. Adapalene\/benzoyl peroxide gel 0.3%\/2.5% for acne vulgaris. European Journal of Dermatology. 2022, 32:445-450. 10.1684\/ejd.2022.4275","journal-title":"European Journal of Dermatology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10344.x","article-title":"A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial","volume":"164","author":"Poulin Y","year":"2011","unstructured":"Poulin Y, Sanchez NP, Bucko A, et al.. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol. 2011, 164:1376-82. 10.1111\/j.1365-2133.2011.10344.x","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdin.2020.12.006","article-title":"Real-world adherence to topical therapies in patients with moderate acne","volume":"2","author":"Lam Hoai XL","year":"2021","unstructured":"Lam Hoai XL, De Maertelaer V, Simonart T, et al.. Real-world adherence to topical therapies in patients with moderate acne. JAAD Int. 2021, 2:109-15. 10.1016\/j.jdin.2020.12.006","journal-title":"JAAD Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2018.3367","article-title":"The safety and efficacy of four different fixed combination regimens of adapalene 0.1%\/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study","volume":"28","author":"Tan J","year":"2018","unstructured":"Tan J, Bissonnette R, Gratton D, Kerrouche N, Canosa JM. The safety and efficacy of four different fixed combination regimens of adapalene 0.1%\/benzoyl peroxide 2.5% gel for the treatment of acne vulgaris: results from a randomised controlled study. Eur J Dermatol. 2018, 28:502-8. 10.1684\/ejd.2018.3367","journal-title":"Eur J Dermatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-021-00552-6","article-title":"Updated treatment for acne: targeted therapy based on pathogenesis","volume":"11","author":"Kurokawa I","year":"2021","unstructured":"Kurokawa I, Layton AM, Ogawa R. Updated treatment for acne: targeted therapy based on pathogenesis. Dermatol Ther (Heidelb). 2021, 11:1129-39. 10.1007\/s13555-021-00552-6","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/229874-safety-and-efficacy-of-fixed-dose-combination-of-adapalene-and-benzoyl-peroxide-in-acne-vulgaris-treatment-a-systematic-review-of-clinical-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:09:27Z","timestamp":1726240167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/229874-safety-and-efficacy-of-fixed-dose-combination-of-adapalene-and-benzoyl-peroxide-in-acne-vulgaris-treatment-a-systematic-review-of-clinical-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.69341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}